AAAAAA
Results:
1-7
|
Results: 7
Authors:
Tonkin, K
Citation: K. Tonkin, Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?, J CL ONCOL, 19(9), 2001, pp. 2579-2580
Authors:
Nabholtz, JM
Mackey, JR
Smylie, M
Paterson, A
Noel, DR
Al-Tweigeri, T
Tonkin, K
North, S
Azli, N
Riva, A
Citation: Jm. Nabholtz et al., Phase II study of docetaxel, doxorubicin, and cyclophosphamide as first-line chemotherapy for metastatic breast cancer, J CL ONCOL, 19(2), 2001, pp. 314-321
Authors:
Nabholtz, JM
North, S
Smylie, M
Mackey, J
Au, HJ
Au, R
Morrish, D
Salter, E
Tonkin, K
Citation: Jm. Nabholtz et al., Docetaxel (Taxotere) in combination with anthracyclines in the treatment of breast cancer, SEMIN ONCOL, 27(2), 2000, pp. 11-18
Authors:
Nabholtz, JM
Lindsay, MA
Hugh, J
Mackey, J
Smylie, M
Au, HJ
Tonkin, K
Allen, M
Citation: Jm. Nabholtz et al., The academic global virtual concept in clinical cancer research and its application to breast cancer: The breast cancer international research group, SEMIN ONCOL, 26(3), 1999, pp. 4-8
Authors:
Nabholtz, JM
Smylie, M
Mackey, J
Au, HJ
Tonkin, K
Au, R
Morrish, D
Salter, E
Citation: Jm. Nabholtz et al., Docetaxel and anthracycline polychemotherapy in the treatment of breast cancer, SEMIN ONCOL, 26(3), 1999, pp. 47-52
Authors:
Nabholtz, JM
Tonkin, K
Smylie, M
Mackey, J
Janowska-Wieczorek, A
Citation: Jm. Nabholtz et al., Review of docetaxel and doxorubicin-based combinations in the management of breast cancer: From metastatic to adjuvant setting, SEMIN ONCOL, 26(1), 1999, pp. 10-16
Authors:
Nabholtz, JM
Mackey, J
Smylie, M
Tonkin, K
Citation: Jm. Nabholtz et al., Taxane-based three-drug combination in metastatic and adjuvant treatment of breast cancer, SEMIN ONCOL, 25(5), 1998, pp. 27-31
Risultati:
1-7
|